SYMPHONIX Trademark
Trademark Overview
On Tuesday, February 19, 2002, a trademark application was filed for SYMPHONIX with the United States Patent and Trademark Office. The USPTO has given the SYMPHONIX trademark a serial number of 78109614. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, January 15, 2006. This trademark is owned by Bristol-Myers Squibb Pharma Company. The SYMPHONIX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging
General Information
| Serial Number | 78109614 |
| Word Mark | SYMPHONIX |
| Filing Date | Tuesday, February 19, 2002 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Sunday, January 15, 2006 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 22, 2002 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases and for diagnostic imaging |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, February 23, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bristol-Myers Squibb Pharma Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 02 - Partnership |
| Address | Wilmington, DE 19810 |
| Party Name | Bristol-Myers Squibb Pharma Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 02 - Partnership |
| Address | Wilmington, DE 19810 |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 22, 2006 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Wednesday, March 22, 2006 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, May 18, 2005 | EXTENSION 5 GRANTED |
| Wednesday, May 18, 2005 | EXTENSION 5 FILED |
| Wednesday, May 18, 2005 | TEAS EXTENSION RECEIVED |
| Thursday, January 13, 2005 | EXTENSION 4 GRANTED |
| Thursday, December 23, 2004 | EXTENSION 4 FILED |
| Thursday, December 23, 2004 | TEAS EXTENSION RECEIVED |
| Monday, August 9, 2004 | CASE FILE IN TICRS |
| Tuesday, July 13, 2004 | EXTENSION 3 GRANTED |
| Wednesday, May 5, 2004 | EXTENSION 3 FILED |
| Saturday, April 10, 2004 | EXTENSION 2 GRANTED |
| Wednesday, January 14, 2004 | EXTENSION 2 FILED |
| Wednesday, July 7, 2004 | PETITION TO REVIVE-GRANTED |
| Wednesday, May 5, 2004 | TEAS EXTENSION RECEIVED |
| Friday, April 16, 2004 | PAPER RECEIVED |
| Monday, February 2, 2004 | PETITION TO REVIVE-RECEIVED |
| Monday, April 5, 2004 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, February 2, 2004 | PAPER RECEIVED |
| Wednesday, May 7, 2003 | EXTENSION 1 GRANTED |
| Tuesday, March 11, 2003 | EXTENSION 1 FILED |
| Tuesday, March 11, 2003 | TEAS EXTENSION RECEIVED |
| Tuesday, January 14, 2003 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 22, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 2, 2002 | NOTICE OF PUBLICATION |
| Monday, August 12, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 18, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 18, 2002 | PAPER RECEIVED |
| Friday, July 5, 2002 | NON-FINAL ACTION MAILED |
| Wednesday, July 3, 2002 | ASSIGNED TO EXAMINER |
